Skip to main content
Erschienen in: Breast Cancer Research 1/2015

Open Access 01.12.2015 | Erratum

Erratum to: Suppression of apoptosis inhibitor c-FLIP selectively eliminates breast cancer stem cell activity in response to the anti-cancer agent, TRAIL

verfasst von: Luke Piggott, Nader Omidvar, Salvador Martí Pérez, Rhiannon French, Matthias Eberl, Richard WE Clarkson

Erschienen in: Breast Cancer Research | Ausgabe 1/2015

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN
Hinweise
Luke Piggott and Nader Omidvar contributed equally to this work.
The online version of the original article can be found under doi:10.​1186/​bcr2945.
The online version of the original article can be found at http://​dx.​doi.​org/​10.​1186/​bcr2945.

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

LP was responsible for the design of the experiments, assembly of data and manuscript writing. NO was responsible for the design of experiments, data collection and manuscript writing. SMP developed a new assay. RF was responsible for the design and execution of experiments for one of the figures. ME handled data analysis and interpretation, funding of research and manuscript writing. RC was responsible for the conception and design of the study, data analysis and interpretation, manuscript writing, final approval of manuscript and funding of research. All authors have read and approved the manuscript for publication.

Correction

While compiling the article [1] one of the authors was inadvertently omitted from the author list. This author, Rhiannon French, has been included in the corrected author list above.

Acknowledgements

We thank Christien Gabriel and Dawn Roberts for technical support. This study was funded by a Tenovus PhD scholarship (LP), seed-corn funding from the Breast Cancer Campaign (RC) and additional part-funding from CR-UK (ME) and BBSRC (NO). RC and ME are RC-UK Research Fellows.

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

LP was responsible for the design of the experiments, assembly of data and manuscript writing. NO was responsible for the design of experiments, data collection and manuscript writing. SMP developed a new assay. RF was responsible for the design and execution of experiments for one of the figures. ME handled data analysis and interpretation, funding of research and manuscript writing. RC was responsible for the conception and design of the study, data analysis and interpretation, manuscript writing, final approval of manuscript and funding of research. All authors have read and approved the manuscript for publication.
Literatur
1.
Zurück zum Zitat Piggott L, Omidvar N, Martí Pérez S, Eberl M, Clarkson RWE. Suppression of apoptosis inhibitor c-FLIP selectively eliminates breast cancer stem cell activity in response to the anti-cancer agent, TRAIL. Breast Canc Res. 2011;13:R88.CrossRef Piggott L, Omidvar N, Martí Pérez S, Eberl M, Clarkson RWE. Suppression of apoptosis inhibitor c-FLIP selectively eliminates breast cancer stem cell activity in response to the anti-cancer agent, TRAIL. Breast Canc Res. 2011;13:R88.CrossRef
Metadaten
Titel
Erratum to: Suppression of apoptosis inhibitor c-FLIP selectively eliminates breast cancer stem cell activity in response to the anti-cancer agent, TRAIL
verfasst von
Luke Piggott
Nader Omidvar
Salvador Martí Pérez
Rhiannon French
Matthias Eberl
Richard WE Clarkson
Publikationsdatum
01.12.2015
Verlag
BioMed Central
Erschienen in
Breast Cancer Research / Ausgabe 1/2015
Elektronische ISSN: 1465-542X
DOI
https://doi.org/10.1186/s13058-015-0597-9

Weitere Artikel der Ausgabe 1/2015

Breast Cancer Research 1/2015 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.